329
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Prophylactic treatment of migraine with botulinum toxin type A: a pharmacoeconomic analysis in a community setting

, MD, , MD, , MD & , CCRC
Pages 355-366 | Accepted 28 Jun 2007, Published online: 28 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Richard B. Lipton, Alan Brennan, Stephen Palmer, Anthony J. Hatswell, Joshua K. Porter, Sandhya Sapra, Guillermo Villa, Neel Shah, Stewart Tepper & David Dodick. (2018) Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective. Journal of Medical Economics 21:7, pages 666-675.
Read now

Articles from other publishers (1)

Ronan Mahon, Andrea Lang, Pamela Vo, Jasper Huels, Philip Cooney, Andriy Danyliv, Umakanth Vudumula, Sreelatha Vadapalle, Farooq Maniyar & Peter J. Goadsby. (2021) Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden. PharmacoEconomics 39:3, pages 357-372.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.